Suppr超能文献

评估肝移植患者的筛查结肠镜检查的产量和安全性。

The Yield and Safety of Screening Colonoscopy in Patients Evaluated for Liver Transplantation.

机构信息

Department of Gastroenterology and Hepatology, Erasmus Medical Center University Hospital, Rotterdam, the Netherlands.

Department of Biostatistics, Erasmus Medical Center University Hospital, Rotterdam, the Netherlands.

出版信息

Hepatology. 2019 Jun;69(6):2598-2607. doi: 10.1002/hep.30562. Epub 2019 Apr 6.

Abstract

Colorectal cancer (CRC) screening with colonoscopy is commonly used in patients who are candidates for liver transplantation. We initiated this study to define the risk-benefit ratio of performing screening colonoscopy in this population. A retrospective observational study of all consecutive patients undergoing colonoscopy during pre-liver transplantation screening between 2004 and 2017 was conducted. Endoscopic and pathological findings and clinical events potentially related to the colonoscopy in the 30 days after the procedure were registered and compared with a 30-day inpatient control time frame. A total of 858 colonoscopies were performed in 808 patients (65% male; median age, 55 years [interquartile range (IQR), 47-62]; median model for end-stage liver disease (MELD) score, 15 [IQR, 11-18]). CRC was found in 2 patients (0.2%), and advanced adenomas were found in 44 patients (5.4%). The only independent risk factor for an advanced neoplasm was age (odds ratio, 1.072 per year; 95% confidence interval, 1.031-1.115; P < 0.001). During the 30-day postprocedure period, 178 clinical events occurred in 128 patients compared with 101 clinical events in 72 patients in the control time frames (P < 0.001). After colonoscopy, there was a significantly increased risk for renal failure (P = 0.001) and gastrointestinal (GI) bleeding (P = 0.023). Presence of ascites and MELD score were identified as independent risk factors for acute renal failure and GI bleeding. During the study observation period, 53.5% of the screened population actually underwent liver transplantation. Conclusion: CRC screening in pre-liver transplantation patients is associated with a relatively low prevalence of CRC and an increased risk of postcolonoscopy complications such as acute renal failure and GI bleeding, especially in patients with advanced liver disease. Because the risk-benefit ratio of standard performance of a screening colonoscopy in this population appears questionable, alternative screening strategies should be considered.

摘要

结直肠癌(CRC)筛查联合结肠镜检查常用于肝移植候选患者。我们开展本研究旨在明确在该人群中进行筛查性结肠镜检查的风险效益比。我们对 2004 年至 2017 年期间所有接受肝移植前筛查结肠镜检查的连续患者进行了回顾性观察性研究。记录内镜和病理检查结果以及术后 30 天内与结肠镜检查相关的临床事件,并与 30 天住院对照时间框架进行比较。共对 808 例患者的 858 例结肠镜检查进行了分析(65%为男性;中位年龄 55 岁[四分位距(IQR):47-62];中位终末期肝病模型(MELD)评分 15[IQR:11-18])。2 例患者(0.2%)发现结直肠癌,44 例(5.4%)发现高级别腺瘤。唯一独立的高级别肿瘤风险因素是年龄(优势比,每年增加 1.072;95%置信区间,1.031-1.115;P<0.001)。术后 30 天内,128 例患者发生 178 例临床事件,72 例患者发生 101 例临床事件(P<0.001)。与对照组相比,结肠镜检查后,肾衰竭(P=0.001)和胃肠道(GI)出血(P=0.023)的风险显著增加。腹水和 MELD 评分被确定为急性肾衰竭和 GI 出血的独立危险因素。研究观察期间,53.5%的筛查人群实际接受了肝移植。结论:在肝移植前患者中进行 CRC 筛查,CRC 的患病率相对较低,但与术后并发症如急性肾衰竭和 GI 出血的风险增加相关,尤其是在患有晚期肝病的患者中。由于在该人群中常规进行筛查性结肠镜检查的风险效益比似乎存在疑问,因此应考虑替代的筛查策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b0a/6593716/c37b6440a8fe/HEP-69-2598-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验